Print Page  |  Close Window

Overview

Corporate Profile

OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. The company’s products and services are designed to enable the rapid identification of hospital patients who are colonized or infected with life-threatening, multi-drug resistant organisms, MDROs.

Upcoming Events

Cowen & Co. 37th Annual Health Care Conference
Monday, March 6, 2017 through Wednesday, March 8, 2017
CIDEIM/ISHA
Wednesday, March 15, 2017 through Friday, March 17, 2017
ECCMID
Saturday, April 22, 2017 through Tuesday, April 25, 2017

More Events

OPGN (Common Stock)
Exchange :NASDAQ CM (US Dollar)
Price :$1.06
Change :0.00 (0.00%)
Volume :0
Data as of 02/17/17 3:54 p.m. ET
Minimum 20 minute delay
Data Provided by Thomson Reuters